Prevention of influenza in the general population: recommendation statement from the Canadian Task Force on Preventive Health Care.
Langley
Joanne M
JM
Canadian Task Force on Preventive Health Care, London, ON.
Faughnan
Marie E
ME
D000081:Acetamides / Q000009:adverse effects / Q000627:therapeutic use*; D000368:Aged; D002170:Canada; D006146:Guanidines; D006291:Health Policy; D006801:Humans; D007223:Infant; D007252:Influenza Vaccines / Q000009:adverse effects; D007251:Influenza, Human / Q000517:prevention & control*; D008875:Middle Aged; D009439:Neuraminidase / Q000037:antagonists & inhibitors; D053139:Oseltamivir; D011315:Preventive Medicine / Q000592:standards; D011634:Public Health; D011714:Pyrans; D012307:Risk Factors; D012794:Sialic Acids / Q000627:therapeutic use*; D053243:Zanamivir
D000081:Acetamides; D006146:Guanidines; D007252:Influenza Vaccines; D011714:Pyrans; D012794:Sialic Acids; D053139:Oseltamivir; D009439:Neuraminidase; D053243:Zanamivir